Anhui Huaheng (China) Today
| 688639 Stock | 32.61 0.34 1.03% |
Performance0 of 100
| Odds Of DistressLess than 31
|
Anhui Huaheng is trading at 32.61 as of the 27th of December 2024, a 1.03% down since the beginning of the trading day. The stock's open price was 32.95. Anhui Huaheng has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 7th of January 2023 and ending today, the 27th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Anhui Huaheng is entity of China. It is traded as Stock on SHG exchange. The company has 249.72 M outstanding shares. More on Anhui Huaheng Biotechnology
Moving together with Anhui Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Anhui Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Anhui Huaheng's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Anhui Huaheng or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Henghua Guo | ||||
| Thematic Idea | Biotech (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Anhui Huaheng's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Anhui Huaheng's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAnhui Huaheng can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Anhui Huaheng's financial leverage. It provides some insight into what part of Anhui Huaheng's total assets is financed by creditors.
| |||||
Anhui Huaheng Biotechnology (688639) is traded on Shanghai Stock Exchange in China and employs 1,691 people. Anhui Huaheng is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.23 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anhui Huaheng's market, we take the total number of its shares issued and multiply it by Anhui Huaheng's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Anhui Huaheng Biotec operates under Biotechnology sector and is part of Health Care industry. The entity has 249.72 M outstanding shares.
Anhui Huaheng generates positive cash flow from operations, but has no cash available
Check Anhui Huaheng Probability Of Bankruptcy
Ownership AllocationAnhui Huaheng holds a total of 249.72 Million outstanding shares. Anhui Huaheng Biotechnology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Anhui Ownership Details
Anhui Huaheng Biotec Risk Profiles
Although Anhui Huaheng's alpha and beta are two of the key measurements used to evaluate Anhui Huaheng's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.59 | |||
| Semi Deviation | 3.97 | |||
| Standard Deviation | 5.27 | |||
| Variance | 27.76 |
Anhui Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Anhui Huaheng without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Anhui Huaheng Corporate Directors
| Yi Fan | Deputy Director | Profile | |
| Dongzhu Zhang | Deputy Director | Profile | |
| Xueli Zhang | Chief Director | Profile | |
| Jian Mao | Deputy Director | Profile |
Other Information on Investing in Anhui Stock
Anhui Huaheng financial ratios help investors to determine whether Anhui Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anhui with respect to the benefits of owning Anhui Huaheng security.